Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-α/IL-1β-induced Human Lung Cells

28 Aug 2022

Abstract excerpt

COVID-19 pandemic has been a global outbreak of coronavirus (SARS-CoV-2 virus) since 2019. Taiwan Chingguan Yihau (NRICM101) is the first traditional Chinese medicine (TCM) classic herbal formula and is widely used for COVID-19 patients in Taiwan and more than 50 nations. This study is to investigate in silico target fishing for the components of NRICM101 and to explore whether NRICM101 inhibits cytokines-induced...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Inflammasome and immune disorders
Share to Mosquito-borne diseases and control

Source

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Identifiers

PMID: 36381194
DOI: 10.37796/2211-8039.1378

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

In silico and in vitro studies of Taiwan Chingguan Yihau (NRICM101) on TNF-α/IL-1β-induced Human Lung CellsPMID 36381194Read ↗

Molecular Basis for Treating COVID-19 with Official Chinese Herbal Formula LCTESemantic proximity Read ↗

Identification of potential key genes for SARS-CoV-2 infected human bronchial organoids based on bioinformatics analysisSemantic proximity Read ↗

Prediction of repurposed drugs for treating lung injury in COVID-19Semantic proximity Read ↗

Single-nucleus lung transcriptomics and inflammatory responses in lethal COVID-19 reveal potential drugs in advanced-stage clinical trialsSemantic proximity Read ↗

Exploring Inflammatory Dysregulation in Alveolar Macrophages: Implications for Novel Therapeutic Targets in Chronic Obstructive Pulmonary DiseaseSemantic proximity Read ↗

Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.Semantic proximity Read ↗

Exploration of Fuzheng Yugan Mixture on COVID-19 based on network pharmacology and molecular dockingSemantic proximity Read ↗

Active constituents and mechanisms of Respiratory Detox Shot, a traditional Chinese medicine prescription, for COVID-19 control and prevention: Network-molecular docking-LC–MSE analysisSemantic proximity Read ↗

The mechanism of Icariside II on NSCLC/COVID-19 based on network pharmacology and molecular dockingSemantic proximity Read ↗

Investigating the mechanism of ShuFeng JieDu capsule for the treatment of novel Coronavirus pneumonia (COVID-19) based on network pharmacologySemantic proximity Read ↗

The identification of Necroptosis-Related Genes and Immune Cell Infiltration in Chronic Obstructive Pulmonary Disease based on bioinformatics and experimental validationSemantic proximity Read ↗

Exploring the Anti-Pulmonary Fibrosis Mechanism of Jingyin Granule by Network Pharmacology StrategySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.